Co-Authors
This is a "connection" page, showing publications co-authored by Davide Corti and Antonio Lanzavecchia.
Connection Strength
1.864
-
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10473-8.
Score: 0.632
-
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
Score: 0.241
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
Score: 0.221
-
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome. J Infect Public Health. 2016 May-Jun; 9(3):231-5.
Score: 0.166
-
Human monoclonal antibodies by immortalization of memory B cells. Curr Opin Biotechnol. 2007 Dec; 18(6):523-8.
Score: 0.093
-
Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
Score: 0.060
-
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
Score: 0.058
-
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. Lancet Reg Health Eur. 2021 Feb; 1:100013.
Score: 0.057
-
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2020 Dec 10; 183(6):1732.
Score: 0.057
-
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020 11 12; 183(4):1024-1042.e21.
Score: 0.056
-
A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature. 2020 08; 584(7821):353-363.
Score: 0.056
-
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2019 02 21; 176(5):1026-1039.e15.
Score: 0.050
-
SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A. 2016 Mar 15; 113(11):3048-53.
Score: 0.041
-
Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J Infect Dis. 2010 Mar 15; 201(6):946-55.
Score: 0.027
-
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. J Virol. 2008 Apr; 82(7):3220-35.
Score: 0.023
-
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A. 2007 Jul 17; 104(29):12123-8.
Score: 0.023